Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

729 Press Releases
DateTitleCompany
17 Nov 15 Global Partners Announce Donation of 500 Millionth Dose of Azithromycin, Marking Exceptional Progress to Help Alleviate the Suffering from Trachoma Pfizer ,
Published by
PharmiWeb.com
05 Nov 15 Pfizer Expands its Patient Assistance Program, Doubling the Income Eligibility Limit to Benefit Even More Patients Taking Pfizer Medicines  Pfizer Inc.,
Published by
Business Wire
04 Nov 15 Merck and Pfizer Announce Initiation of Phase III First-Line Trial of Avelumab in Patients with Recurrent or Stage IV Non-Small Cell Lung Cancer Pfizer,
Published by
Business Wire
04 Nov 15 Merck KGaA, Darmstadt, Germany, and Pfizer Announce Initiation of Phase III First-Line Trial of Avelumab in Patients with Recurrent or Stage IV Non-Small Cell Lung Cancer Pfizer Inc.,
Published by
Business Wire
31 Oct 15 Pfizer Inc. Announcement under Rule 2.10 of the Irish Takeover Rules – Relevant Securities in Issue Pfizer Inc.,
Published by
Business Wire
29 Oct 15 Pfizer Announcement Regarding Allergan plc Pfizer,
Published by
Business Wire
29 Oct 15 Pfizer Announces Collaboration with GSK on Next-Generation Design of Portable, Continuous, Miniature and Modular (PCMM) Oral Solid Dose Development and Manufacturing Units Pfizer Inc.,
Published by
Business Wire
14 Oct 15 Pfizer Receives Complete Response Letter from FDA for Oral XELJANZ® (tofacitinib citrate) Supplemental New Drug Application for Moderate to Severe Chronic Plaque Psoriasis Pfizer Inc.,
Published by
Business Wire
09 Oct 15 Pfizer’s Phase 2 Study Demonstrates Safety, Tolerability and Immunogenicity of TRUMENBA® When Coadministered with Meningococcal A, C, Y and W-135 Polysaccharide Conjugate (MCV4) and Tetanus, Diphtheria and Pertussis (Tdap) Vaccines in Adolescents Pfizer Inc.,
Published by
Business Wire
07 Oct 15 Merck KGaA, Darmstadt, Germany, and Pfizer Announce Investigational Immunotherapy Avelumab Receives FDA Fast Track Designation for Metastatic Merkel Cell Carcinoma Pfizer,
Published by
Business Wire
07 Oct 15 Merck and Pfizer Announce Investigational Immunotherapy Avelumab Receives FDA Fast Track Designation for Metastatic Merkel Cell Carcinoma Pfizer,
Published by
Business Wire
02 Oct 15 Pfizer Inc. Announces Final Results of Exchange Offers Pfizer ,
Published by
PharmiWeb.com
02 Oct 15 Pfizer Completes Acquisition Of Nimenrix And Mencevax From GlaxoSmithKline Pfizer ,
Published by
PharmiWeb.com
02 Oct 15 Pfizer Partners with Breast Cancer Leaders to Chronicle the Lives of Women with Metastatic Breast Cancer through the Lenses of Prominent Photographers Pfizer ,
Published by
PharmiWeb.com
02 Oct 15 Pfizer Inc. Announces Final Results of Exchange Offers Pfizer Inc.,
Published by
Business Wire
01 Oct 15 Pfizer Completes Acquisition Of Nimenrix And Mencevax From GlaxoSmithKline Pfizer Inc.,
Published by
Business Wire
01 Oct 15 Pfizer Partners with Breast Cancer Leaders to Chronicle the Lives of Women with Metastatic Breast Cancer through the Lenses of Prominent Photographers Pfizer Inc.,
Published by
Business Wire
30 Sep 15 Is 50 Really the New 30? Your Immune System May Not Think So Pfizer,
Published by
Business Wire
09 Sep 15 Pfizer Inc. Commences Exchange Offers for Hospira Notes Pfizer ,
Published by
PharmiWeb.com
09 Sep 15 Pfizer Completes Acquisition of Hospira Pfizer ,
Published by
PharmiWeb.com
15 Sep 15 Pfizer Invites Public to View and Listen to Webcast of October 27 Conference Call with Analysts Pfizer Inc.,
Published by
Business Wire
23 Sep 15 Pfizer Announces Positive Top-Line Results from Two Phase 3 Trials of Oral Tofacitinib in Adults with Moderate-to-Severe Ulcerative Colitis Pfizer ,
Published by
Pharmiweb.com
24 Sep 15 Pfizer’s Sayana® Press Becomes First Injectable Contraceptive In The United Kingdom Available For Administration By Self-Injection Pfizer Inc.,
Published by
Business Wire
24 Sep 15 Merck and Pfizer Collaborate with Dako, an Agilent Technologies Company, on Development of Companion Diagnostic for Investigational anti-PD-L1 Antibody, Avelumab Pfizer,
Published by
Business Wire
24 Sep 15 Merck KGaA, Darmstadt, Germany, and Pfizer Collaborate with Dako, an Agilent Technologies Company, on Development of Companion Diagnostic for Investigational anti-PD-L1 Antibody, Avelumab Pfizer,
Published by
Business Wire
25 Sep 15 Merck KGaA, Darmstadt, Germany, and Pfizer Announce FDA Orphan Drug Designation for Investigational Immunotherapy Avelumab in Merkel Cell Carcinoma Pfizer,
Published by
Business Wire
25 Sep 15 Pfizer Declares 28-Cent Fourth-Quarter 2015 Dividend Pfizer Inc.,
Published by
Business Wire
18 Sep 15 Pfizer Inc. Announces Results of Early Tenders and Consents in Exchange Offers Pfizer Inc.,
Published by
Business Wire
22 Sep 15 New Centrum® VitaMints® Offer a Refreshingly New Way to Take a Multivitamin Pfizer,
Published by
Business Wire
23 Sep 15 New Centrum® VitaMints® Offer a Refreshingly New Way to Take a Multivitamin Pfizer ,
Published by
Pharmiweb.com
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.